Presynaptic modulation controlling neuronal excitability and epileptogenesis: Role of kainate, adenosine and neuropeptide Y receptors

Neurochemical Research

Volumn 28, Issue 10, 2003, Pages 1501-1515

  Malva, João O ^a   Silva, Ana P ^a   Cunha, Rodrigo A ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Adenosine receptors; Epilepsy; Glutamate; Hippocampus; Kainate receptors; Neuropeptide Y receptors

Indexed keywords

ADENOSINE RECEPTOR; ANTICONVULSIVE AGENT; GLUTAMIC ACID; KAINIC ACID RECEPTOR; NEUROPEPTIDE Y RECEPTOR;

EPILEPSY; EPILEPTOGENESIS; GABAERGIC TRANSMISSION; HIPPOCAMPUS; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NEUROMODULATION; NEUROTOXICITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SEIZURE; SIGNAL TRANSDUCTION;

ANIMALS; EPILEPSY; HUMANS; NEURONS; RECEPTORS, KAINIC ACID; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, PRESYNAPTIC; RECEPTORS, PURINERGIC P1;

EID: 0141593557     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025618324593     Document Type: Review

References (247)

1. deLorenzo, R. J., Towne, A. R., Pellock, J. M., and Ko, D. J. 1992. Status epilepticus in children, adults and the elderly. Epilepsia 33(Suppl. 4): S15-S25.
2. Schmidt, D. and Kràmer, G. 1994. The new anticonvulsant drugs: Implications for avoidance of adverse effects. Drug Safety 11:422-431.
3. Dalby, N. O. and Mody, I. 2001. The process of epileptogenesis: A pathophysiological approach. Curr. Opin. Neurol. 14:187-192.
4. Mathern, G. W., Babb, T. L., Leite, J. P., Pretorius, K., Yeoman, K. M., and Kuhlman, P. A. 1996. The pathogenic and progressive features of chronic human epilepsy. Epilepsy Res. 26:151-161.
5. Cole, A. J. 2000. Is epilepsy a progressive disease? The neurobiological consequences of epilepsy. Epilepsia 41(Suppl. 2): S13-S22.
6. Racine, R. J. 1972. Modification of seizure activity by electrical stimulation. I. Afterdischarge threshold. Electroencephalogr. Clin. Neurophysiol. 32:269-279.
7. Racine, R. J. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:281-294.
8. Cavazos, J. E. and Sutula, T. P. 1990. Progressive neuronal loss induced by kindling: A possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis. Brain Res. 527:1-45.
9. Cavazos, J. E., Das, I., and Sutula, T. P. 1994. Neuronal loss induced in limbic pathways by kindling: Evidence for induction of hippocampal sclerosis by repeated brief seizures. J. Neurosci. 14:106-121.
10. Bengzon, J., Kokaia, Z., Elmer, E., Nanobashvili, A., Kokaia, M., and Lindvall, O. 1997. Apoptosis and proliferation of dentate gyrus neurons after single and intermitent limbic seizures. Proc. Natl. Acad. Sci. USA 94:10432-10437.
11. Tasch, E., Cendes, F., Li, L. M., Dubeau, F., Andermann, F., and Arnold, D. L. 1999. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann. Neurol. 45:568-576.
12. DeGiorgio, C. M., Tomiyasu, U., Gott, P. S., and Treiman, D. M. 1992. Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia 33:23-27.
13. Wieshmann, U. C., Woermann, F. G., Lemieux, L., Free, S. L., Bartlett, P. A., Smith, S. J., Duncan, J. S., Stevens, J. M., and Shorvon, S. D. 1997. Development of hippocampal atrophy: A serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus. Epilepsia 38:1238-1241.
14. Willow, M., Gonoi, T., and Catterall, W. A. 1985. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol. Pharmacol. 27:549-558.
15. Bonifácio, M. J., Sheridan, R. D., Parada, A., Cunha, R. A., Patmore, L., and Soaresda-Silva, P. 2001. Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: Comparison with carbamazepine. Epilepsia 42:600-608.
16. Reynolds, E. H. 1995. Do anticonvulsants alter the natural time course of epilepsy? Treatment should be started as early as possible. Br. Med. J. 301:176-180.
17. Coutinho-Netto, J. C., Abdul-Ghani, A. S., Collins, J. F., and Bradford, H. F. 1981. Is glutamate a trigger factor in epileptic hyperactivity? Epilepsia 22:289-296.
18. Chapman, A. G. 1998. Glutamate receptors in epilepsy. Prog. Brain Res. 116:371-383.
19. Löscher, W. 1998. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog. Neurobiol. 54:721-741.
20. Cain, D. P. 1989. Long-term potentiation and kindling: How similar are the mechanisms? Trends Neurosci. 12:6-10.
21. Lipton, P. 1999. Ischemic cell death in brain neurons. Physiol. Rev. 79:1431-1568.
22. Michaelis, E. K. 1998. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog. Neurobiol. 54:369-415.
23. Lees, G. J. 2000. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs 59:33-78.
24. MacDermott, A. B., Role, L. W., and Siegelbaum, S. A. 1999. Presynaptic ionotropic receptors and the control of transmitter release. Ann. Rev. Neurosci. 22:443-485.
25. Schoepp, D. D. 2001. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 299:12-20.
26. Ben-Ari, Y. 1985. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14:375-403.
27. Coyle, J. T. 1983. Neurotoxic action of kainic acid. J. Neurochem. 41:1-11.
28. Represa, A., Tremblay, E., and Ben-Ari, Y. 1987. Kainate binding sites in the hippocampal mossy fibers: Localization and plasticity. Neuroscience 20:739-748.
29. Gaiarsa, J.-L., Zagrean, L., and Ben-Ari, Y. 1994. Neonatal irradiation prevents the formation of hippocampal mossy fibers and the epileptic action of kainate on rat CA3 pyramidal neurons. J. Neurophysiol. 71:204-215.
30. Ben-Ari, Y. and Cossart, R. 2000. Kainate: A double agent that generates seizures-Two decades of progress. Trends Neurosci. 23:580-587.
31. Chittajallu, R., Braithwaite, S. P., Clarke, V. R. J., and Henley, J. M. 1999. Kainate receptor: Subunits, synaptic localization and function. Trends Pharmacol. Sci. 20:26-35.
32. Lerma, J., Paternain, A. V., Rodríguez-Moreno, A., López-García, J. C. 2001. Molecular physiology of kainate receptors. Physiol. Rev. 81:971-998.
33. Rosenmund, C., Stern-Bach, Y., and Stevens, C. F. 1998. The tetrameric structure of a glutamate receptor channel. Science 280:1596-1599.
34. Malva, J. O., Carvalho, A. P., and Carvalho, C. M. 1998. Kainate receptors in hippocampal CA3 subregion: Evidences for a role in regulating neurotransmitter release. Neurochem. Int. 32:1-6.
35. Herb, A., Burnashev, N., Werner, P., Sakmann, B., Wisden, W., and Seeburg, P. H. 1992. The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits. Neuron 8:775-785.
36. Patneau, D. K., Wright, P. W., Winters, C., Mayer, M. L., and Gallo, V. 1994. Glial cells of the oligodendrocyte lineage express both kainate-and AMPA-preferring subtypes of glutamate receptor. Neuron 12:357-371.
37. Huettner, J. E. 1990. Glutamate receptor channels in rat DRG neurons: Activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron 5:255-266.
38. Bleakman, D. and Lodge, D. 1998. Neuropharmacology of AMPA and kainate receptors. Neuropharmacol. 37:1187-1204.
39. Bleakman, D. 1999. Kainate receptor pharmacology and physiology. Cell. Mol. Life Sci. 56:558-566.
40. Castillo, P. E., Malenka, R. C., and Nicoll, R. A. 1997. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature 388:182-186.
41. Vignes, M. and Collingridge, G. L. 1997. The synaptic activation of kainate receptors. Nature 388:179-182.
42. Chittajallu, R., Vignes, M., Dev, K. K., Barnes, J. M., Collingridge, G. L., and Henley, J. M. 1996. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379:78-81.
43. Cunha, R. A. and Ribeiro, J. A. 2001. ATP as a presynaptic modulator. Life Sci. 68:119-137.
44. Mulle, C., Sailer, A., Pérez-Otaño, I., Bureau, I., Maron, C., Gage, F. H., Mann, J. R., Bettler, B., and Heinemann, S. F. 1998. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392:601-605.
45. Hollmann, M. and Heinemann, S. 1994. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:31-108.
46. Malva, J. O., Ambrósio, A. F., Cunha, R. A., Ribeiro, J. A., Carvalho, A. P., and Carvalho, C. M. 1995. A functionally active presynaptic high-affinity kainate receptor in the rat hippocampal CA3 subregion. Neurosci. Lett. 185:83-86.
47. Malva, J. O., Carvalho, A. P., and Carvalho, C. M. 1996. Domoic acid induces the release of glutamate in the rat CA3 sub-region. Neuroreport 7:1330-1334.
48. Cunha, R. A., Constantino, M. D., and Ribeiro, J. A. 1997 Inhibition of H3-gamma-aminobutyric acid release by kainate receptor activation in rat hippocampal synaptosomes. Eur. J. Pharmacol. 323:167-172.
49. Lerma, J., Partenain, A. V., Naranjo, J. R., and Mellström, B. 1993. Functional kainate-selective glutamate receptors in cultured hippocampal neurons. Proc. Natl. Acad. Sci. USA 90:11688-11692.
50. Clarke, V. R. J., Ballyk, B. A., Hoo, K. H., Mandelzys, A., Pellizzari, A., Bath, C. P., Thomas, J., Sharpe, E. F., Davies, C. H., Ornstein, P. L., Schoepp, D. D., Kamboj, R. K., Collingridge, G. L., Lodge, D., and Bleakman, D. 1997. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389:599-603.
51. Rodríguez-Moreno, A., Herreras, O., and Lerma, J. 1997. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron 19:893-901.
52. 3H]kainic acid binding sites in rat CNS as determined by autoradiography. Brain Res. 252:91-100.
53. Petralia, R. S., Wang, Y. X., and Wenthold, R. J. 1994. Histological and ultrastructural localization of the kainate receptors, KA2 and GluR6/7, in the rat nervous system using selective antipeptide antibodies. J. Comp. Neurol. 349:85-110.
54. Bettler, B. and Mulle, C. 1995. Neurotransmitter receptors II: AMPA and kainate receptors. Neuropharmacol. 34:123-139.
55. 2+ influx at the hippocampal mossy fiber synapses. J. Neurosci. 22:9237-9243.
56. Lauri, S. E., Bortolotto, Z. A., Bleakman, D., Ornstein, P. L., Lodge, D., Isaac, J. T. R., and Collingridge, G. L. 2001. A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP. Neuron 32:697-709.
57. Lauri, S. E., Delany, C., Clarke, V. R. J., Bortolotto, Z. A., Ornstein, P. L., Isaac, J. T. R., and Collingridge, G. L. 2001. Synaptic activation of a presynaptic kainate receptor facilitates AMPA receptor-mediated synaptic transmission at hippocampal mossy fiber synapses. Neuropharmacol. 41:907-915.
58. Schmitz, D., Mellor, J., Frerking, M., and Nicoll, R. A. 2001. Presynaptic kainate receptors at hippocampal mossy fiber synapses. Proc. Natl. Acad. Sci. USA 98:11003-11008.
59. Schmitz, D., Mellor, J., and Nicoll, R. A. 2001. Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses. Science 291:1972-1976.
60. Teitelbaum, J. S., Zatorre, R. J., Carpenter, S., Gendron, D., Evans, A. C., Gjedde, A., and Cashman, N. R. 1990. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N. Engl. J. Med. 322:1781-1787.
61. Contractor, A., Swanson, G. T., Sailer, A., O'Gorman, S., and Heinemann, S. F. 2000. Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J. Neurosci. 20:8269-8278.
62. Vignes, M., Clarke, V. R. J., Parry, M. J., Bleakman, D., Lodge, D., Ornstein, P. L., and Collingridge, G. L. 1998. The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus. Neuropharmacol. 37:1269-1277.
63. Bortolotto, Z. A., Clarke, V. R. J., Delany, C. M., Parry, M, C., Smolders. I., Vignes, M., Ho, K. H., Miu, P., Brinton, B. T., Fantaske, R., Ogden, A., Gates, M., Ornstein, P. L., Lodge, D., Bleakman, D., and Collingridge, G. J. 1999. Kainate receptors are involved in synaptic plasticity. Nature 402:297-301.
64. Bahn, S., Volk, B., and Wisden, W. 1994. Kainate receptor gene expression in the developing rat brain. J. Neurosci. 14:5525-5547.
65. Phillips, G. R., Huang, J. K., Wang, Y., Tanaka, H., Shapiro, L., Zhang, W., Shan, W.-S., Arndt, K., Frank, M., Gordon, R. E., Gawinowicz, M. A., Zhao, Y., and Colman, D. R. 2001. The presynaptic particle web: Ultrastructure, composition, dissolution, and reconstitution. Neuron 32:1-20.
66. Pinheiro, P. S., Rodrigues, R. J., Silva, A. P., Cunha, R. A., Oliveira, C. R., and Malva, J. O. 2003. Solubilization and immunological identification of presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in the rat hippocampus. Neurosci. Lett. 336:97-100.
67. 2+ influx and EPSP in area CA1 of the rat hippocampus. J. Physiol. 509:833-845.
68. Kamiya H. and Ozawa, S. 2000. Kainate receptor-mediated presynaptic inhibition at the mouse hippocampal mossy fibre synapse. J. Physiol. 523:653-665.
69. Frerking, M., Schmitz, D., Zhou, Q., Johansen, J., and Nicoll, R. A. 2001. Kainate receptors depress excitatory synaptic transmission at CA3-CA1 synapses in the hippocampus via a direct presynaptic action. J. Neurosci. 21:2958-2966.
70. Burnashev, N., Villaroel, A., and Sackmann, B. 1996. Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R site residues. J. Physiol. 496:165-173.
71. Rodrígues-Moreno, A. and Lerma, J. 1998. Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 20:1211-1218.
72. Cunha, R. A., Malva, J. O., and Ribeiro, J. A. 1999. Kainate receptors coupled to Gi/Go proteins in the rat hippocampus. Mol. Pharmacol. 56:429-433.
73. 3H]GABA release is pertussistoxin-sensitive in the rat hippocampus. FEBS Lett. 469:159-162.
74. Rodríguez-Moreno, A., López-Garcia, J. C., and Lerma, J. 2000. Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons. Proc. Natl. Acad. Sci. USA 97:1293-1298.
75. Semyanov, A. and Kullmann, D. M. 2001. Kainate receptor-dependent axonal depolarization and action potential initiation in interneurons. Nat. Neurosci. 4:718-723.
76. Cossart, R., Esclapez, M., Hirsch, J. C., Bernard, C., and Ben-Ari, Y. 1998. GluR5 kainate receptor activation in interneurons increases tonic inhibition of pyramidal cells. Nat. Neurosci. 1:470-478.
77. Frerking, M., Malenka, R. C., and Nicoll, R. A. 1998. Synaptic activation of kainate receptors on hippocampal interneurons. Nat. Neurosci. 1:479-486.
78. Bureau, I., Bischoff, S., Heinemann, S. F., and Mulle, C. 1999. Kainate receptor-mediated response in the CA1 field of wild-type and GluR6-deficient mice. J. Neurosci. 19:653-663.
79. Mulle, C., Sailer, A., Swanson, G. T., Brana, C., O'Gorman, S., Bettler, B., and Heinemann, S. F. 2000. Subunit composition of kainate receptors in hippocampal interneurons. Neuron 28: 475-484.
80. Paternain, A. V., Herrera, M. T., Nieto, M. A., and Lerma, J. 2000. GluR5 and GluR6 kainate receptor subunits coexist in hippocampal neurons and coassemble to form functional receptors. J. Neurosci. 20:196-205.
81. Frerking, M., Petersen, C. C., and Nicoll, R. A. 1999. Mechanisms underlying kainate receptor-mediated disinhibition in the hippocampus. Proc. Natl. Acad. Sci. USA 96:12917-12922.
82. Cossart, R., Tyzio, R., Dinocourt, C., Esclapez, M., Hirsch, J. C., Ben-Ari, Y., and Bernard, C. 2001. Presynaptic kainate receptors that enhance the release of GABA on CA1 hippocampal interneurons. Neuron 29:497-508.
83. Jiang, L., Xu, J., Nedergaard, M., and Kang, J. 2001. A kainate receptor increases the efficacy of GABAergic synapses. Neuron 30:503-513.
84. Kullmann, D. M. and Semyanov, A. 2002. Glutamatergic modulation of GABAergic signaling among hippocampal interneurons: Novel mechanisms regulating hippocampal excitability. Epilepsia 43:174-178.
85. Cunha, R. A. 2001. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: Different roles, different sources and different receptors. Neurochem. Int. 38:107-125.
86. Dunwiddie, T. V. and Masino, S. A. 2001. The role and regulation of adenosine in the central nervous system. Ann. Rev. Neurosci. 24:31-55.
87. Dunwiddie, T. V. 1985. The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27:63-139.
88. Greene, R. W. and Haas H. L. 1991. The electrophysiology of adenosine in the mammalian central nervous system. Prog. Neurobiol. 36:329-341.
89. Phillis, J. W. and Wu P. H. 1981. The role of adenosine and its nucleotides in central synaptic transmission. Prog. Neurobiol. 16:187-239.
90. Dunwiddie, T. V. 1980. Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 21:541-548.
91. Mitchell, J. B., Lupica, C. R., and Dunwiddie, T. V. 1993. Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci. 13: 3439-3447.
92. Cunha, R. A. 2001. Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem. Res. 26: 979-991.
93. Zimmermann, H. and Braun, N. 1999. Ecto-nucleotidases: Molecular structures, catalytic properties, and functional roles in the nervous system. Prog. Brain Res. 120:371-385.
94. Latini, S. and Pedata, F. 2001. Adenosine in the central nervous system: Release mechanisms and extracellular concentrations. J. Neurochem. 79:463-484.
95. Lambert, N. A. and Tyler, T. J. 1991. Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus. Neurosci. Lett. 122:50-52.
96. Yoon, K. W. and Rothman, S. M. 1991. Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus. J. Neurosci. 11:1375-1380.
97. Proctor, W. R. and Dunwiddie, T. V. 1987. Pre-and postsynaptic actions of adenosine in the in vitro hippocampus. Brain Res. 426:187-190.
98. Thompson, S. M., Hass, H. L., and Gahwiller, B. H. 1992. Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J. Physiol. 451: 347-363.
99. 1 receptor. Eur. J. Pharmacol. 340:301-310.
100. 2+ channels by adenosine autoreceptors. Nature 365:256-258.
101. Wu, L. G. and Saggau, P. 1994. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12:1139-1148.
102. 2+ channels. J. Neurophysiol. 76:39-46.
103. Scholz, K. P. and Miller, R. J. 1992. Inhibition of quantal transmitter release in the absence of calcium influx by a G protein-linked adenosine receptor at hippocampal synapses. Neuron 8:1139-1150.
104. Capogna, M., Gähwiler, B. H., and Thompson, S. M. 1996. Presynaptic inhibition of calcium-dependent and calcium-dependent and calcium-independent release elicited with ionomycin, gadolinium, and α-latrotoxin in the hippocampus. J. Neurophysiol. 75:2017-2028.
105. Dittman, J. S. and Regehr, W. G. 1996. Contributions of calcium-dependent and calcium-independent mechanisms to presynaptic inhibition at a cerebellar synapse. J. Neurosci. 16:1623-1633.
106. Silinsky, E. M., Hirsh, J. K., Searl, T. J., Redman, R. S., and Watanabe, M. 1999. Quantal ATP release from motor nerve endings and its role in neurally mediated depression. Prog. Brain Res. 120:145-158.
107. Tetzlaff, W., Schubert, G. W., and Kreutzberg, G. W. 1987. Synaptic and extrasynaptic localization of adenosine binding sites in the rat hippocampus. Neuroscience 21:869-875.
108. 1 receptor activation. Neuroreport 6:1097-1100.
109. 1 adenosine receptors. Proc. Natl. Acad. Sci. USA 92:12431-12435.
110. 2+ currents in hippocampal CA3 neurons. Neuron 10:327-334.
111. 2+ channel subtypes in acutely isolated rat basolateral amygdala neurons. Br. J. Pharmacol. 132:879-888.
112. de Mendonça, A. and Ribeiro, J. A. 2001. Adenosine and synaptic plasticity. Drug Dev. Res. 52:283-290.
113. de Mendonça, A., Sebastião, A. M., and Ribeiro, J. A. 2000. Adenosine: Does it have a neuroprotective role after all? Brain Res. Rev. 33:258-274.
114. Sebastião, A. M., de Mendonça, A., Moreira, T., and Ribeiro, J. A. 2001. Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J. Neurosci. 21:8564-8571.
115. + current, IAHP, by reducing adenylyl cyclase activity in rat CA3 hippocampal neurons. J. Neurophysiol. 72:2360-2367.
116. + channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19:687-695.
117. 1 adenosine receptors. J. Neurosci. 22:1248-1255.
118. Barraco, R. A., Swanson, T. H., Phillis, J. W., and Berman, R. F. 1984. Anticonvulsant effects of adenosine analogues on amygdaloid-kindled seizures in rats. Neurosci. Lett. 46: 317-322.
119. Dragunow, M. and Goddard, G. V. 1984. Adenosine modulation of amygdala kindling. Exp. Neurol. 84:654-665.
120. Dragunow, M., Goddard, G. V. and Laverty, R. 1985. Is adenosine an endogenous anticonvulsant? Epilepsia 26:480-487.
121. Dunwiddie, T. V. and Worth, T. 1982. Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J. Pharmacol. Exp. Ther. 220:70-76.
122. Eldridge, F. L., Paydarfar, D., Scott, S. C., and Dowell, R. T. 1989. Role of endogenous adenosine in recurrent generalized seizures. Exp. Neurol. 103:179-185.
123. 1 receptor activation mediates suppresion of (-)-bicuculline methiodide-induced seizures in rat prepiriform cortex. J. Pharmacol. Exp. Ther. 251:1229-1236.
124. 6-cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats. Neuropharmacology 40:657-667.
125. Maitre, M., Chesielski, L., Lehmann, A., Kempf, E., and Mandel, P. 1974. Protective effect of adenosine and nicotinamide against audiogenic seizures. Biochem. Pharmacol. 23: 2807-2816.
126. Petersen, E. N. 1991. Selective protection by adenosine agonists of DMCM-induced seizures. Eur. J. Pharmacol. 195:256-261.
127. Rosen, L. B. and Berman, R. F. 1987. Differential effects of adenosine analogs on amygdala, hippocampus and caudate nucleus kindled seizures. Epilepsia 28:658-666.
128. 1 receptors in the rat brain in the kindling model of epilepsy. Eur. J. Pharmacol. 265: 121-124.
129. Turski, W. A., Cavalheiro, E. A., Ikonomidou, C., Moraes-Mello, L. E. A., Bortolotto, Z. A., and Turski, L. 1985. Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: Morphological and electroencephalographic correlates. Brain Res. 361:309-323.
130. 6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-asparte-induced seizures in mice. Eur. J. Pharmacol. 249:265-270.
131. Young, D. and Dragunow, M. 1994. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 58:245-261.
132. Dunwiddie, T. V. 1999. Adenosine and suppression of seizures. Pages 1001-1010, in Delgado-Escueta, A. V., Wilson, W. A., Olsen, R. W., and Porter, R. J. (eds.), Jasper's Basic Mechanisms of the Epilepsies, 3rd ed., Advances in Neurology, Vol. 79, Lippincott Williams & Wilkins, Philadelphia.
133. Dragunow, M. 1988. Purinergic mechanisms in epilepsy. Prog. Neurobiol. 31:85-108.
134. Ault, B. and Wang, C. M. 1986. Adenosine inhibits epileptiform activity arising in hippocampal area CA3. Br. J. Pharmacol. 87:695-703.
135. Lee, K. S., Schubert, P., and Heinemann, U. 1984. The anti-convulsant action of adenosine: A postsynaptic dendritic action by a possible endogenous anticonvulsant. Brain Res. 321:160-164.
136. 1 receptor-mediated mechanisms in the juvenile rat hippocampus. J. Pharmacol. Exp. Ther. 286:1412-1419.
137. Dragunow, M. 1986. Adenosine: The brain's natural anticonvulsant. Trends Pharmacol. Sci. 7:128-130.
138. Chu, N. S. 1981. Caffeine- and aminophylline-induced seizures. Epilepsia 22:85-94.
139. Dragunow, M. and Robertson, H. A. 1987. 8-Cyclopentyl-1,3-dimethylxanthine prolongs epileptic seizures in rats. Brain Res. 417:377-379.
140. Francis, A. and Fochtmann, L. 1994. Caffeine augmentation of electroconvulsive seizures. Psycopharmacology 115:320-324.
141. Kostopoulos, G., Drapeau, C., Avoli, M., Olivier, A., and Villemeure, J. G. 1989. Endogenous adenosine can reduce epileptiform activity in the human epileptogenic cortex maintained in vitro. Neurosci. Lett. 106:119-124.
142. Mori, H., Mizutani, T., Yoshimura, M., Yamanouchi, H., and Shimada, H. 1992. Unilateral brain damage after prolonged hemiconvulsions in the elderly associated with theophylline administration. J. Neurol. Neurosurg. Psychiatry 55: 466-469.
143. Peters, S. G., Wochos, D. N., and Peterson, G. C. 1984. Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy. Mayo Clin. Proc. 59:568-570.
144. Whitcomb, K., Lupica, C. R., Rosen, J. B., and Berman, R. F., 1990. Adenosine involvement in postictal events in amygdala-kindled rats. Epilepsy Res. 6:171-179.
145. 1 receptor-mediated inhibitory tonus: Pre- and postsynaptic components. Neuroscience 57:565-575.
146. Ault, B., Olney, M. A., Joyner, J. L., Boyer, C. E., Notrica, M. A., Soroko, F. E., and Wang, C. M. 1987. Pro-convulsant actions of theophylline and caffeine in the hippocampus: Implications for the management of temporal lobe epilepsy. Brain Res. 426:93-102.
147. Chesi, A. J. R. and Stone, T. W. 1997. Alkylxanthine adenosine antagonists and epileptiform activity in rat hippocampal slices in vitro. Exp. Brain Res. 113:303-310.
148. Berman, R. F., Fredholm, B. B., Aden, U., and O'Connor, W. T. 2000. Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats. Brain Res. 872:44-53.
149. During, M. J., and Spencer, D. D. 1992. Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 32:618-624.
150. Lewin, E. and Bleck, V. 1981. Electroshock seizures in mice: Effect on brain adenosine and its metabolites. Epilepsia 22:577-581.
151. Park, T. S., van Wylen, D. G. L., Rubio, R., and Berne, R. M., 1987. Interstitial fluid adenosine and sagital sinus blood flow during bicuculline-seizures in newborn piglets. J. Cereb. Blood Flow Metabol. 7:633-639.
152. Schrader, J., Wahl, M., Kuschinsky, W., and Kreutzberg, G. N. 1980. Increase of adenosine content in cerebral cortex of the cat during bicuculline-induced seizure. Pflügers Arch. 387:245-251.
153. Winn, H. R., Welsh, J. E., Bryner, C., Rubio, R., and Berne, R. N. 1979. Brain adenosine production during the initial 60 seconds of bicuculline seizures in rats. Acta Physiol. Scand. 72:536-537.
154. Winn, H. R., Welsh, J. E., Rubio, R., and Berne, R. N. 1980. Changes in brain adenosine during bicuculline-induced seizures in rats: Effects of hypoxia and altered systemic blood pressure. Circ. Res. 47:868-877.
155. Kulkarni, C., David, J., and Joseph, T. 1994. Involvement of adenosine in postictal events in rats given electroshock. Indian J. Physiol. Pharmacol. 38:39-43.
156. Fredholm, B. B. 1997. Adenosine and neuroprotection. Int. Rev. Neurobiol. 40:259-280.
157. Brodie, M. S., Lee, K. S., Fredholm, B. B., Stahle L., and Dunwiddie, T. V. 1987. Central versus peripheral mediation of responses to adenosine receptor agonists: Evidence against a central mode of action. Brain Res. 415:323-330.
158. Katims, J. J., Annau, Z., and Snyder, S. H. 1983. Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J. Pharmacol. Exp. Ther. 227:167-173.
159. Malhotra, J. and Gupta, Y. K. 1997. Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br. J. Pharmacol. 120:282-288.
160. Huber, A., Padrum, V., Déglon, N., Aebischer, P., Mölher, H., and Boison, D. 2001. Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. USA 98:7611-7616.
161. Ashton, D., de Prins, E., Willems, R., van Belle, H., and Wauquier, A. 1988. Anticonvulsant action of the nucleoside transport inhibitor, soluflazine, on synaptic and non-synaptic epileptogenesis in the guinea-pig hippocampus. Epilepsy Res. 2:65-71.
162. Zhang, G., Franklin, P. H., and Murray, T. F. 1993. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264:1415-1424.
163. Wiesner, J. B., Ugarkar, B. G., Castellino, A. J., Barankiewicz, J., Dumas, D. P., Gruber, H. E., Foster, A. C., and Erion, M. D. 1999. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J. Pharmacol. Exp. Ther. 289:1669-1677.
164. 1-adenosine receptors associated with reduced sensitivity to anticonvulsants. Neuropharmacology 26:1173-1180.
165. Janusz, C. A. and Berman, R. F. 1993. The adenosine binding enhancer, PD 81,723, inhibits epileptiform bursting in the hippocampal brain slice. Brain Res. 619:131-136.
166. 1 adenosine receptors in nucleus reticularis thalami in rats with genetic absence epilepsy. Neuroreport 9:2135-2140.
167. 1 adenosine receptors in rat hippocampus after kainic acid-induced limbic seizures. Neurosci. Lett. 284:49-52.
168. 1 adenosine receptors in human temporal lobe epilepsy. Brain Res. 710:56-68.
169. 1 receptors in epilepsy. Neuroreport 10:3535-3541.
170. 1 adenosine receptors in different mouse brain areas afer pentylentetrazol-induced seizures, but not in the epileptic mutant mouse 'tottering.' Brain Res. 534:251-256.
171. 1 receptors and their coupling to G proteins following seizures in the developing rat. Dev. Brain Res. 59:237-247.
172. 1 receptors within rat hippocampus. Neurochem. Res. 26:225-230.
173. 1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur. J. Neurosci. (in press).
174. Wieraszko, A. and Seyfried, T. N. 1989. Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice. Neurosci. Lett. 106:287-293.
175. Vianna, E. P., Ferreira, A. T., Naffah-Mazzacoratti, M. G., Sanabria, E. R., Funke, M., Cavalheiro, E. A., and Fernandes, M. J. 2002. Evidence that ATP participates in the pathophysiology of pilocarpine-induced temporal lobe epilepsy: Fluorimetric, immunohistochemical, and Western blot studies. Epilepsia 43(Suppl. 5):227-229.
176. Bonan, C. D., Amaral, O. B., Rockenbach, I. C., Walz, R., Battastini, A.
177. Bonan, C. D., Walz, R., Pereira, G. S., Worm, P. V., Battastini, A. M., Cavalheiro, E. A., Izquierdo, I., and Sarkis, J. J. 2000. Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy. Epilepsy Res. 39:229-238.
178. Nagy, A. K., Houser, C. R., and Delgado-Escueta, A. V. 1990. Synaptosomal ATPase activities in temporal cortex and hippocampal formation of humans with focal epilepsy. Brain Res. 529:192-201.
179. Schoen, S. W., Ebert, U., and Loscher, W. 1999. 5′-Nucleotidase activity in mossy fibers in the dentate gyrus of normal and epileptic rats. Neuroscience 93:519-526.
180. 3H]nitrobenzylthioinosine adenosine uptake binding in the mouse brain after acute pentylenetetrazol-induced seizures. J. Neurosci. Res. 53:433-442.
181. Cunha, R. A., Correia-de-Sá, P., Sebastião, A. M., and Ribeiro, J. A. 1996. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol. 119:253-260.
182. 2A receptors and therapeutic applications. Curr. Top. Med. Chem. 3:1349-1364.
183. 2A receptor agonists on pentylenetetrazole-induced convulsions in the rat. Eur. J. Pharmacol. 294:383-389.
184. De Sarro, G., De Sarro, A., Paola, E. D., and Bertorelli, R. 1999. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice. Eur. J. Pharmacol. 371: 137-145.
185. 2A receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci. Lett. 329:289-292.
186. 2 receptor ligands in different chemoconvulsive rodent models. Eur. J. Pharmacol. 242:221-228.
187. Morgan, P. F. and Durcan, M. J. 1990. Caffeine-induced seizures: Apparent proconvulsant action of N-ethylcarboxamidoadenosine (NECA). Life Sci. 47:1-8.
188. 2 receptor stimulation on hypoxia-induced convulsions in adult mice. Pol. J. Pharmacol. 53:83-92.
189. 1 receptor underlies anticonvulsant effect of CGS21680. Eur. J. Pharmacol. 255:239-243.
190. 2A receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology 40:424-432.
191. 2A receptor deficient mice are more resistant to seizures. Proc. 3rd Forum Eur. Neurosci.
192. 2A receptor antagonists. Br. J. Pharmacol. 135:1435-1442.
193. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19:9192-9200.
194. 2A adenosine receptor inactivation in a model of Parkinson's disease. J. Neurosci. 21:RC143.
195. 2A receptor blockade of β-amyloid neurotoxicity. Br. J. Pharmacol. 138:1207-1209.
196. 2A receptor blockade in experimental models of Parkinson's disease. J. Neurochem. 80:262-270.
197. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. Neuroreport 9:3955-3959.
198. 2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: Possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J. Neurosci. 22:1967-1975.
199. 2 receptor antagonist prevents frontal cortex EEG abnomalities in a rat model of Huntington's disease. Brain Res. 831:315-318.
200. 2a receptors in the rat hippocampus. Brain Res. 649:208-216.
201. 2a receptor gene by hypoxia in PC12 cells; A potential role in cell protection. J. Biol. Chem. 274:20358-20365.
202. 2A receptors in the cerebral cortex of kindled rats. Proc. 23th Meet. Portuguese Pharmacol. Soc. C64.
203. 2A adenosine receptor activation. Proc. 23th Meet. Portuguese Pharmacol. Soc. C66.
204. Lee, F. S. and Chao, M. V. 2001. Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc. Natl. Acad. Sci. USA 98:3555-3560.
205. Ernfors, P., Bengzon, J., Kokais, Z., Persson, H., and Lindvall, O. 1991. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 7:165-176.
206. Kokaia, M., Ernfors, P., Kokaia, Z., Elmer, E., Jaenisch, R., and Lindvall, O. 1995. Suppressed epileptogenesis in BDNF mutant mice. Exp. Neurol. 133:215-224.
207. Binder, D. K., Routbort, M. J., Ryan, T. E., Yancopoulos, G. D., and McNamara, J. O. 1999. Selective inhibition of kindling development by intraventricular administration of TrkB receptor body. J. Neurol. Sci. 19:1424-1436.
208. 2A receptor antagonist. Eur. J. Pharmacol. 406:345-354.
209. 2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxy-dopamine-lesioned rats. Synapse 39:233-238.
210. 2A receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats: Lack of tolerance after chronic caffeine intake. Neuropsychopharmacology 22:522-529.
211. 2A receptors in the limbic cortex, but not striatum, of aged rats. J. Neurochem. 73:1733-1738.
212. 2A receptor facilitation of synaptic transmission in the hippocampus of aged rats. J. Neurophysiol. in press.
213. Kimmel, J. R., Hayden, L. J., and Pollock, H. G. 1975. Isolation and characterization of a new pancreatic polypeptide hormone. J. Biol. Chem. 250:9369-9374.
214. Larhammar, D., Blomqvist, A. G., and Söderberg, C. 1993. Evolution of neuropeptide Y and its related peptides. Comp. Biochem. Physiol. 106C:743-752.
215. Larhammar, D., Söderberg, C., and Blomqvist, A. G. 1993. Evolution of neuropeptide Y family of peptides. Pages 141, in Colmers, W. F. and Wahlestedt, C. (eds.), The Biology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, New Jersey.
216. Allen, J. M. and Baldi, D. 1993. Structure and expression of the neuropeptide Y gene. Pages 43-64, in Colmers, W. F. and Wahlestedt, C. (eds.). The Biology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, New Jersey.
217. Sundler, F., Böttcher, G., Ekblad, E., and Håkanson, R. 1993. PP, PYY and NPY: Occurrence and distribution in the periphery. Pages 157-196, in Colmers, W. F. and Wahlestedt, C. (eds.), The Biology of Neuropeptide Y and Related Peptides, Humana Press, Totowa, New Jersey.
218. Lundberg, J. M. 1996. Pharmacology and cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 48:113-178.
219. Michel, M. C., Beck-Sickinger, A., Cox, H., Doods, H. N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T., and Wesffall, T. 1998. XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Revi. 50:143-150.
220. Larhammar, D. 1996. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept. 65:165-174.
221. Schwarzer, C., Sperk, G., Rizzi, M., Gariboldi, M., and Vezzani, A. 1996. Neuropeptides-immunoractivity and their mRNA expression in kindling: Functional implications for limbic epileptogenesis. Brain Res. Rev. 22:27-50.
222. Vezzani, A., Sperk, G., and Colmers, W. F. 1999. Neuropeptide Y: Emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22:25-30.
223. Gruber, G., Greber, S., Rupp, E., and Sperk, G. 1994. Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid injection. Hippocampus 4:474-482.
224. Takahashi, Y., Tsunashima, K., Sadamatsu, M., Schwarzer, C., Amano, S., Ihara, N., Sasa, M., Kato, N., and Sperk, G. 2000. Altered hippocampal expression of neuropeptide Y, somastotatin, and glutamate decarboxylase in Ihara's epileptic rats and spontaneously epileptic rats. Neurosci. Lett. 287:105-108.
225. Klapstein, G. J. and Colmers, W. F. 1997. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol. 78:1651-1661.
226. Patrylo, P. R., Van Den Pol, A. N., Spencer, D. D., and Williamson, A. 1999. NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J. Neurophysiol. 82: 478-483.
227. Van den Pol, A. N., Obrietan, K., Chen, G., and Belousov, A. B. 1996. Neuropeptide Y-mediated long-term depression of excitatory activity in suprachiasmatic nucleus neurons. J. Neurosci. 16:5883-5895.
228. Baraban, S. C., Hollopeter, G., Erickson, J. C., Schwartzkroin, P. A., and Palmiter, R. D. 1997. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17:8927-8936.
229. Vezzani, A., Michalkiewicz, M., Michalkiewicz, T., Moneta, D., Ravizza, T., Richichi, C. et al. 2002. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110:237-243.
230. 2 receptor. Br. J. Pharmacol. 102:41-44.
231. Woldbye, D. P. D., Larsen, P. J., Mikkelsen, J. D., Klemp, K., Madsen, T. M., and Bolwig, T. G. 1997. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat. Med. 3:761-764.
232. Kopp, J., Nanobashvili, A., Kokaia, Z., Lindvall, O., and Hökfelt, T. 1999. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis. Mol. Brain Res. 72:17-29.
233. Röder, C., Schwarzer, C., Vezzani, A., Gobbi, M., Minnini, T., and Sperk, G. 1996. Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience 70:47-55.
234. Bleakman, D., Harrison, N. L., Colmers, W. F., and Miller, R. J. 1992. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurones of the rat. Br. J. Pharmacol. 107:334-340.
235. 2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J. Neurophysiol. 76:3159-3168.
236. Vezzani, A., Rizzi, M., Conti, M., and Samanin, R. 2000. Modulatory role of neuropeptide in seizures induced in rats by stimulation of glutamate receptors. Am. Soc. Nutri. Sci. 7402:1046S-1048S.
237. t receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. J. Neurosci. 16:1422-1429.
238. 1 receptors. Eur. J. Neurosci. 10:757-759.
239. Brooks, P. A., Kelly, J. S., Allen, J. M., Smith, D. A. S., and Stone, T. W. 1987. Direct excitatory effects of neuropeptide Y (NPY) in rat hippocampal neurons in vitro. Brain Res. 408:295-298.
240. 2 receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices. Eur. J. Pharmacol. 404:133-136.
241. 2 receptors in the rat hippocampus: Differential effects in CA1, CA3 and dentate gyrus. J. Neurochem. 79:286-296.
242. 2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 113:737-740.
243. Silva, A. P., Carvalho, A. P., Carvalho, C. M., and Malva, J. O. 2003. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44:282-292.
244. Marsh, D. J., Baraban, S. C., Hollopeter, G., and Palmiter, R. D. 1999. Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc. Natl. Acad. Sci. USA 96:13518-13523.
245. Guo, H., Castro, P. A., Palmiter, R. D., and Baraban, S. C. 2002. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus. J. Neurophysiol. 87:558-566.
246. Dinger, M. C., Bader, J. E., Kobor, A. D., Kretzschmar, A. K., and Beck-Sickinger, A. G. 2003. Homodimerization of neuropeptide Y receptors investigated by fluorescence resonance energy transfer in living cells. J. Biol. Chem. 278:10562-10571.
247. Silva, A. P., Pinheiro, P. S., Carvalho, A. P., Carvalho, C. M., Jakobsen, B., Zimmer, J. and Malva, J. O. 2003. Activation of neuropeptide Y receptors is neuroprotective against excitoxicity in organotypic hippocampal slice cultures. FASEB J. 17:1118-1120.